Virtual Library
Start Your Search
V. Rexha
Author of
-
+
P3.16 - Surgery (ID 732)
- Event: WCLC 2017
- Type: Poster Session with Presenters Present
- Track: Surgery
- Presentations: 1
- Moderators:
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.16-005 - Outcome, Mortality and Morbidity after Lung Cancer Thoracic Surgery (ID 7899)
09:30 - 09:30 | Author(s): V. Rexha
- Abstract
Background:
Introduction:Lung cancer is the most common form and cause of cancer death world-wide. Radical surgical resection, with or without adjuvant treatment, is still a prerequisite for cure.In European countries the proportion of patients who undergo surgery for this disease varies between 10 and 30% .Advances in operative and postoperative care have led to a decline in complications and mortality rates during the last two decades.In spite of different additional modes of treatment, survival is still poor.
Method:
The study comprised 388 consecutive patients referred to University Hospital of Lung Disease Tirane, from a defined population, during a 12-years period (2004-2017).There were in total 968 patients who underwent lung resection for bronchogenic carcinoma.There were 690 males and 278 females included 15-87 years with a mean age of 65.5 years.Postoperative events studied were divided into major and minor complications or death during the first 30 days after surgery.
Result:
Early mortality (within 30 days) after lung cancer surgery.During the study period an increasing number of women and of patients older than 70 years underwent surgery.The 30 day mortality rate was 3.4% (33 patients), 1.2% after single lobectomy(11 patients) and 3.1 % after pneumonectomy(22 patients).Major complications occurred in 48 patients (4.9%). Minor complications occurred in 75 patients (7.7%).Male gender, smoker, FEV1 70% of expected value, squamous cell carcinoma and pneumonectomy were risk factors predicting adverse outcome .
Conclusion:
Our results show low mortality and morbidity after lung cancer surgery.However, patients with reduced lung capacity and those undergoing pneumonectomy should be treated with great care, as they run a considerable risk of major complications or death during the first 30 days postoperatively.Older age (>70 years) does not appear to be a contraindication to lung cancer surgery, but patients in this group should undergo careful preoperative evaluation.
